
zzso hypersensitivity is a well-known adverse reaction but the prevalence varies and data for frequency and clinical features have not been reported for zzso Here we evaluates the prevalence and risk factors for hypersensitivity reactions to zzso after zzso 

Clinical information on all patients treated with zzso was zzso reviewed in electronic medical records between August 2009 and July 2010 in Seoul National University zzso zzso Patients who experienced hypersensitivity reactions to zzso were compared with those who did zzso 

A total of zzso patients received zzso with 42 zzso experiencing hypersensitivity reactions including three cases of zzso Median cycle of the first hypersensitivity reaction was zzso zzso correlated with lower zzso zzso Other variables were not zzso 

The prevalence of hypersensitivity reactions was zzso symptoms being mostly mild and zzso Lower zzso doses could be a predictor for hypersensitivity reactions to zzso 

